David Bown, a 41-year-old IT systems manager from Atherstone, is suing the NHS after suffering irreversible brain damage caused by prolonged chemotherapy treatment. Originally diagnosed with a low-grade brain tumour, David was prescribed temozolomide by University Hospitals Coventry and Warwickshire NHS Trust. However, instead of following clinical guidelines recommending six months of chemotherapy, he was treated for over eight years.
David’s ordeal began about a decade ago when seizures led to scans revealing a brain tumour. Following surgery to remove the tumour, critical protocols were missed: an MRI scan was not performed within 48 hours post-operation, delaying the identification of dangerous brain bleeding and swelling. When a scan was finally conducted four days later, emergency surgery was urgently needed but postponed. This delay resulted in a stroke and a subsequent coma, necessitating another operation to remove a blood clot and drain fluid.
Legal experts argue that these delays were pivotal in causing permanent brain damage. Despite these complications, David continued on temozolomide chemotherapy far beyond the recommended duration, exposing him to unnecessary risks, including heightened chances of secondary blood cancers.
READ MORE: Asda Urges Shoppers to Use £20 Discount Code Before Saturday Midnight Deadline
READ MORE: I’m on Universal Credit – How to Claim a Free £150 Clothing Allowance and Other Benefits
Before his diagnosis, David led an active life—working, coaching children’s football, and socializing. Today, he faces significant cognitive and visual impairments, relying on his parents for daily activities such as managing medication, meal preparation, and attending medical appointments. The prolonged treatment has also led to depression, further affecting his quality of life.
David shares his heartbreak: “I went from living a normal, active life to being completely dependent on my mum and dad for everything. I trusted the hospital to do what was best for me but looking back, I just can’t understand why I was treated the way I was for so long. It has taken everything from me. I cry myself to sleep at night – I dream that I can see, and then I wake up and I cannot. It’s a nightmare.”
His lawyers at Brabners highlight a series of failures, including inadequate consent procedures, surgical planning errors, delayed recognition of complications, and the excessive duration of chemotherapy. Fiona Tinsley, a partner at Brabners, remarks, “David was a young man with his whole future ahead of him. The cumulative effect of these failings has robbed him of his independence, his health, and years of his life.”
The legal team has uncovered evidence suggesting that David’s case is part of a wider problem at the University Hospitals Coventry and Warwickshire NHS Trust. Over 30 patients have now initiated legal action over similar allegations of negligent cancer care. The emerging pattern involves multiple departments—neuro-oncology, neurosurgery, neuroradiology, nursing, and pharmacy—raising concerns about systemic issues within the trust.
Tinsley adds, “What started as concerns about chemotherapy administration now reveals systemic failings across various practices. Patients were told they had months to live without treatment, yet endured years of toxic therapy that caused harm rather than healing. The consequences include physical injuries, psychological distress, loss of careers, fertility, and overall quality of life. Some have developed infertility, early menopause, or secondary leukaemia necessitating stem cell transplants. All face elevated risks of secondary cancers.”
“These patients deserve answers, accountability, and assurance that the NHS has learned from these failings to prevent them from happening again. This is a matter of public interest.”
University Hospitals Coventry and Warwickshire NHS Trust responded, “We are committed to providing the safest possible care for our patients. As this is an ongoing legal matter, we are unable to comment further at this stage.”